Pharmacogenetics of Oral Antidiabetic Drugs
Oral antidiabetic drugs (OADs) are used for more than a half-century in the treatment of type 2 diabetes. Only in the last five years, intensive research has been conducted in the pharmacogenetics of these drugs based mainly on the retrospective register studies, but only a handful of associations d...
Saved in:
Main Authors: | Matthijs L. Becker, Ewan R. Pearson, Ivan Tkáč |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2013/686315 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessing the Roles of Molecular Markers of Antimalarial Drug Resistance and the Host Pharmacogenetics in Drug-Resistant Malaria
by: Peter Hodoameda, et al.
Published: (2022-01-01) -
Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers
by: Andrea Rodríguez-Lopez, et al.
Published: (2024-12-01) -
Pharmacogenetic markers of colorectal cancer treatment. New approaches for cytostatic drugs efficacy estimation
by: N. B. Zakharzhevskaya, et al.
Published: (2015-12-01) -
Pharmacogenetics of Chronic Pain and Its Treatment
by: Svatopluk Světlík, et al.
Published: (2013-01-01) -
Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents
by: Amilton Dos Santos-Júnior, et al.
Published: (2016-01-01)